About The Zdenko Kos Foundation
The primal objects for which the Charity is established are the supporting medical researches of all kinds, specially cancer research, support for emerging visual and performing artists and sports talents including water sports for disadvantaged young people in United Kingdom and Europe.
The Zdenko Kos Foundation, in collaboration with communities around the United Kingdom and Europe and network partners, connects the people, data and resources needed to address challenging health problems associated with all sorts of cancer or other medical issues, along to support positive changes in people lives, to promotes education, policy, research and systemic change that will foster measurable and sustainable improvement for all people living with cancer or other medical issues or simply because of difficult way of living.
The ”dream team” of nearly 200 highly qualified scientists, doctors, surgeons, consultants, researchers, lab experts, ... was formed who started with research back in 2011/2012 along with hospital/ clinical trials started in December 2014. Our work was carried out in the United Kingdom, Italy, Germany and Switzerland. During the covid our work has not been “closed down”, even more, was intensified and we worked better and harder because majority was on stand-by with their main jobs at hospitals due to the covid where majority governments closed the hospitals.
The team during the years expand to 317 who worked in 229 different hospitals (some of them are working in 3-4 hospitals at the same time), 58 labs, there were 43 freelancers, while others are having their own private clinics or labs like the founder in Switzerland.
The research was fully funded, the starting budget was £308.2m. There were supporters, financiers and donors who like the dream team wanted some progress to be made with cancers. Thanks to all of them the team manage to come to the end with researches and results - the best medications and techniques without any shadow of the doubt.
Understanding of Cancer's has grown substantially over the past 14 years.
The Kos Foundation is building on this momentum to explore prevention of the disease and transform diagnosis and treatments.
Years of work spent uncovering Cancer’s secrets > defining the highly variable patient experience, shedding light on genetic origins of disease, mapping molecular pathways — are now paying off in a tangible quickening tempo of scientific progress.
Investigators are increasingly linking cellular pathology to outward clinical symptoms (and vice versa) to identify new therapeutic and biomarker targets. This has positioned drug makers to make rapid inroads toward treatments that have the potential to slow or stop progression of Cancer's disease (CD).
The field also is closer than ever to arriving at therapies that can treat all the symptoms of CD, including the less well understood non-visible aspects, such as eg. with brain cancer patients persistently feeling sick (nausea), being sick (vomiting) and drowsiness, mental or behavioural changes, such as memory problems or changes in personality, progressive weakness or paralysis on one side of the body up to vision or speech problems.